STERIS (NYSE:STE) (NYSE: STE) provides products and services designed to support infection prevention, surgical procedures, and the manufacture of healthcare and pharmaceutical products. The company serves healthcare providers, pharmaceutical and biotechnology manufacturers, and other organizations that require controlled, sterile environments.
Its Healthcare segment offers sterilization and decontamination equipment, operating-room products, surgical instruments, endoscopy products, consumables, and related maintenance and procedural services. STERIS also provides contract sterilization and laboratory services through its Applied Sterilization Technologies business, while its Life Sciences operations supply equipment, consumables, and services for pharmaceutical and biopharmaceutical production, cleanrooms, and research facilities.
Founded in 1987, STERIS has expanded through organic development and acquisitions and serves customers across North America, Europe, Asia-Pacific, and other international markets. The company is headquartered in Mentor, Ohio. Dan Carestia serves as STERIS’s president and chief executive officer.
